Adherence Improvement in Glaucoma Patients

The purpose of this study is to study the effect on intraocular pressure in glaucoma patients using the TravAlert dosing aid with or without the Eyot drop guider and with or without additional patient education.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jeroen Bosch ziekenhuis, 's-Hertogenbosch, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis glaucoma or ocular hypertension
Treatment with travoprost or travoprost/timolol

Exclusion criteria

High risk of side effects expected from travoprost or travoprost/timolol
Absolute inability to administer eye drops
Difficulty in reading or speaking Dutch

Treatment and study plan

Use of TravAlert dosing aid with or without drop guider

Device

Each patient will use a dosing aid and/or drop guider for 6 months

Primary outcomes

Intraocular pressure

Time frame: 6 months

Secondary outcomes

Information with regard to the use of eye drops from data generated by the TravAlert dosing system

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Collaborators

Alcon Research

Registry information

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2010
First posted: Jan 28, 2008
Registry last updated: Feb 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed